Accueil   Diary - News   All news Nosopharm joins ENABLE project

Nosopharm joins ENABLE project

Nosopharm joins European Gram-negative Antibacterial Engine (ENABLE) project to combat antibiotic resistance

 

The company aims to advance NOSO-95179, a promising antibacterial compound, to clinical stage for the treatment of multidrug-resistant Gram-negative infections

 

 

Nosopharm, a biotechnology company specialized in the research and development of new antibacterial molecules, announced it has been selected to join ENABLE (European Gram-negative Antibacterial Engine), a project working to advance the development of potential antibiotics against multidrug resistant Gram-negative infections.

 

Read the press release

 

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree